This is just a question on a policy that would achieve the end that everyone is seeking.
Recognizing that the R-and-D-based pharmaceutical industry is providing drugs at cheaper prices, in certain cases in the developing world, if CIDA were to approach the pharmaceutical industry and say that these are the drugs we need for these countries, and agree that we would pay for them, would the R-and-D-based pharmaceutical firms offer the drugs at cost? If the concern is patent protection, if the concern is the potential loss of the integrity of the patent system, would the R-and-D-based industry provide, at cost, drugs to the developing world if CIDA, acting on behalf of the developing world, were to offer to buy them?